Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Pays $2M for Rights to Genicon s Signal Detection Technology

NEW YORK, July 8 - Invitrogen has paid Genicon Sciences $2 million for the rights to its nanoparticle signal generation and detection technology and products, the companies said today.

 

Genicon, of San Diego, uses gold and silver particles in its technology, Resonance Light Scattering, or RLS, and has used it for detection of proteins and nucleic acids, including in DNA and protein microarrays. Genicon launched a DNA microarray toolkit in July 2002, and has co-distributed the toolkit with Qiagen.

 

Invitrogen said it plans to continue the co-distribution agreement with Qiagen for the DNA microarray toolkit, but will retain the exclusive worldwide commercialization rights for protein and other applications of RLS.

 

"The extraordinary sensitivity of the RLS technology allows researchers to detect low abundance molecules directly and to better monitor biological interactions such as nucleic acid hybridization," John Carrino, Invitrogen's VP for Research and Development, said in a statement. "The demand for highly-sensitive detection technologies has grown dramatically in recent years as rare targets are implicated in disease and the use of small, micro-dissected tissue samples becomes more prevalent in research."

 

Invitrogen is headquartered in Carlsbad, Calif.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.